SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) --
When: May 17–22, 2024
Where: San Diego Convention Center (SDCC) | 111 Harbor Dr. San Diego, CA 92101
Marriott Marquis San Diego Marina | 333 West Harbor Dr. San Diego, CA 92101
Research: 26 ResMed-supported abstracts will be presented at ATS. Full list below. Highlights:
- Treatment of Sleep-Disordered Breathing with Adaptive Servo-Ventilation (READ-ASV)
in Opioid Users – a European Registry- Sunday May 19, 2024, 9:15 a.m. - 11:15 a.m., SDCC 32A-B
- Presented by Jean-Louis Pepin, MD, Grenoble Alpes University, France
- An Estimate of the Prevalence of Obstructive Sleep Apnea in the United States into 2050
- Monday, May 20, 9:15 a.m. - 4:15 p.m., SDCC Area C Hall A-B2
- Presented by Elroy Boers, PhD, ResMed Science Center
- All-Cause Mortality in Obstructive Sleep Apnea
- Monday, May 20, 2:15 p.m. - 4:15 p.m., SDCC 32A-B
- Presented by Atul Malhotra, MD, University of California, San Diego
- Impact of Positive Airway Pressure (PAP) Therapy on Hospitalization in Obstructive Sleep Apnea (OSA): Analysis of a German Healthcare Database
- Monday, May 20, 2:15 p.m. - 4:15 p.m., SDCC 32A-B
- Presented by Holger Woehrle, MD, Ulm Lung Centre, Germany
- Treatment of Sleep-Disordered Breathing with Adaptive Servo-Ventilation – Outcomes in Patients with Treatment-Emergent or Persistent Central Sleep Apnea
- Tuesday, May 21, 2:15 p.m. - 4:15 p.m., Marriott Marquis Pacific Ballroom 15-17
- Presented by Michael Arzt, MD, Universitätsklinikum Regensburg, Germany
Innovation Hub: Healthcare of Today, Looking Towards Tomorrow: Digital Innovations and Patient Centricity
- Monday, May 20, 1:15 - 1:35 p.m., SDCC Innovation Hub 4
- Presented by Monica Mallampalli, Chief Executive Officer at Alliance of Sleep Apnea Partners, and Carlos Nunez, ResMed Chief Medical Officer
Booth #1442: Featuring ResMed's latest innovations in respiratory care:
- AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea
- AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed's Smallest Full-Face CPAP Mask
Complete list of ResMed sponsored studies to be presented at ATS 2024:
Treatment of sleep-disordered breathing with adaptive servo-ventilation (READ-ASV) in opioid users – a European registry | Sunday, May 19, 2024 9:15 AM -11:15 AM |
8-year Trends in Obesity, Type 2 Diabetes, and Glucagon-like Peptide-1 (GLP-1) Use in Patients With Obstructive Sleep Apnea | Sunday May 19, 2024 9:15 AM - 11:15 AM |
Impact of CPAP Termination on Permanent Work Disability in Obstructive Sleep Apnea: A French Nationwide Alaska Database Analysis | Sunday May 19, 2024 9:15 AM - 4:15 PM |
Tailoring Social Support to Improve PAP Therapy Usage in Obstructive Sleep Apnea | Sunday May 19, 2024 9:15 AM - 4:15 PM |
Examining Alignment of Patient Medication-taking Behaviors With Inhaler Usage Recommendations in Chronic Obstructive Pulmonary Disease and Asthma | Sunday May 19, 2024 9:15 AM - 4:15 PM |